XML 14 R4.htm IDEA: XBRL DOCUMENT v3.20.4
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Net Sales:    
Total net sales $ 4,869,652 $ 4,511,428
Cost of sales:    
Total cost of sales 2,303,829 1,909,781
Gross profit 2,565,823 2,601,647
Operating expenses:    
Research and development 600,298 666,615
Selling, general and administrative 1,733,154 1,703,274
Total operating expenses 2,333,452 2,369,889
Operating income 232,371 231,758
Interest income 879 78,870
Other income 16,392 17,280
Income before income taxes 249,642 327,908
Income tax expense 9,497 0
Net income $ 240,145 $ 327,908
Net income per common share:    
Basic (in dollars per share) $ 0.01 $ 0.02
Diluted (in dollars per share) $ 0.01 $ 0.02
Weighted average shares outstanding:    
Basic (in shares) 17,214,384 16,909,036
Diluted (in shares) 17,216,287 17,081,578
Product    
Net Sales:    
Total net sales $ 4,802,835 $ 4,458,694
Cost of sales:    
Total cost of sales 2,294,294 1,844,480
Engineering development contracts    
Net Sales:    
Total net sales 66,817 52,734
Cost of sales:    
Total cost of sales $ 9,535 $ 65,301